At a glance

ClinicalIndex Comparison Record

N/ACompleted· 105 enrolled

Drug / intervention

Whole exome sequencinggenetic

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03276637

NCT03276637N/ACompleted

Compare CT.gov

The MilSeq Project: Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air Force

Brigham and Women's Hospital·interventional·Posted Sep 8, 2017·Updated Oct 2, 2024

In Brief

A clinical study evaluating Whole exome sequencing for Healthy Adults and Genetic Predisposition to Disease. Completed, enrolled 105 participants across 3 sites.

Detailed Summary

The MilSeq Project is a nonrandomized, prospective pilot study of whole exome sequencing (WES) in the U.S. Air Force. The purpose of this study is to explore the implementation of WES into clinical medical care in the military health system.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsHealthy Adults, Genetic Predisposition to Disease

CountriesUnited States

CollaboratorsUnited States Department of Defense

Timeline

N/ACompletedFinished

201820192020202120222023202420252026

Enrollment StartAug 2017

First PostedSep 2017

Primary CompletionJun 2019

Study CompletionJan 2020

TodayJul 2026

First PostedSep 8, 2017

Enrollment StartAug 23, 2017

Primary CompletionJun 22, 2019

Study CompletionJan 11, 2020

TodayJul 2, 2026

Enrollment to primary: 1.8 yearsPosted 8.8 years ago

Interventions

Whole exome sequencinggenetic

Whole exome sequencing at 125x coverage (i.e., at least 125 sequencing reads covering each position within the exome region of interest) performed at the Laboratory of Molecular Medicine's Clinical Laboratory Improvement Amendments (CLIA) certified laboratory on 75 enrolled individuals